http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0104566-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 1983-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0104566-B1
titleOfInvention Process for the preparation of 5,11-dihydro-11-((4-methyl-1-piperazinyl)-acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one
abstract 1. Process for preparing 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H- -pyrido[2,3-b][1,4]-benzodiazepin-6-one or the salts thereof with inorganic or organic acids, characterised in that 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one of formula I see diagramm : EP0104566,P8,F1 is reacted in a solvent conventionally used for lithiation reactions first with at least two equivalents of a lithium alkyl or lithium aryl at temperatures of between -60 and 0 degrees C and subsequently with a (4-methyl-1-piperazinyl)-acetate of general formula III see diagramm : EP0104566,P8,F2 wherein R represents an alkyl group with 1 to 10 carbon atoms, a phenyl or phenylalkyl group with 1 to 3 carbon atoms in the alkyl part, and the compound thus obtained is isolated and, if desired, converted into the salts thereof with inorganic or organic acids.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7123562-B2
priorityDate 1982-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10932176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7912
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228533050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226547193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2762732

Total number of triples: 30.